Clarity Pharmaceuticals (CU6) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CU6 Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Dr Boreham’s Crucible: It’s a long way to the top if you want to roll prostate cancer, but Clarity is a clear contenderAugust 14 at 5:30 PM | msn.comClarity Pharmaceuticals Expands Market Presence with New Securities QuotationAugust 10, 2025 | tipranks.comClarity Pharmaceuticals Issues New Shares to Bolster Financial PositionAugust 10, 2025 | tipranks.comClarity Pharmaceuticals Issues New Equity Securities to Boost Employee IncentivesAugust 4, 2025 | msn.comScott Power: ASX health stocks stumble but rotation into sector ‘picks up steam’August 1, 2025 | msn.comClarity Pharmaceuticals Strengthens Financial Position and Advances Clinical TrialsJuly 31, 2025 | tipranks.comClarity confidence – and share price – up on bumper $203M institutional placementJuly 28, 2025 | msn.comClarity Pharmaceuticals Secures $203 Million in Institutional PlacementJuly 27, 2025 | tipranks.comClarity Pharmaceuticals readies mega capital raisingJuly 27, 2025 | afr.comBroker says this ASX 200 biotech stock is a top buyJuly 25, 2025 | msn.comCU6 - Clarity Pharmaceuticals Ltd Valuation - MorningstarJuly 18, 2025 | morningstar.comMClarity Pharmaceuticals Issues Over 1.9 Million New SharesJuly 1, 2025 | tipranks.comClarity Pharmaceuticals Expands Capital with New Securities IssuanceJune 23, 2025 | tipranks.comWhy Clarity Pharmaceuticals, Kelsian, Life360, and Syrah shares are rising todayJune 18, 2025 | msn.comBell Potter says this ASX 200 stock can rise 100%+June 11, 2025 | msn.comThursday's HotCopper trends: Firefly hits brakes, Clarity DISCO results | June 5, 2025June 4, 2025 | msn.comClarity Pharmaceuticals’ 64Cu-SARTATE Outperforms Standard Imaging in Phase II TrialJune 4, 2025 | tipranks.comVanguard Group Reduces Stake in Clarity PharmaceuticalsJune 4, 2025 | tipranks.comFirst patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CTMay 29, 2025 | finance.yahoo.comGuess which ASX 200 stock is jumping 10% on big newsMay 29, 2025 | msn.comClarity Pharmaceuticals: First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CTMay 29, 2025 | finanznachrichten.deClarity Pharmaceuticals Issues New Equity Securities for Employee IncentiveMay 29, 2025 | tipranks.comClarity Pharmaceuticals Advances Phase III AMPLIFY Trial for Prostate Cancer ImagingMay 28, 2025 | tipranks.comClarity Pharmaceuticals: Registrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commencesMay 20, 2025 | finanznachrichten.deRegistrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commencesMay 20, 2025 | finance.yahoo.comHealth Check: There’s no Biden time as Clarity launches prostate cancer study aimed at early detectionMay 20, 2025 | msn.comClarity Pharmaceuticals Launches Phase III Trial for Prostate Cancer DiagnosticMay 19, 2025 | tipranks.comTrump executive order to hit these 3 ASX pharmaceutical stocksMay 14, 2025 | msn.com3 ASX Penny Stocks With Market Caps Larger Than A$500MMay 13, 2025 | finance.yahoo.comSECuRE trial update: First patient treated in the Phase II Cohort ExpansionApril 17, 2025 | morningstar.comMClarity signs high-volume commercial-scale copper-64 Supply Agreement with NusanoApril 17, 2025 | gurufocus.comClarity scribes deal on delivery of copper 64 isotopesApril 17, 2025 | msn.comClarity Pharmaceuticals Secures Copper-64 Supply Agreement with NusanoApril 16, 2025 | tipranks.comClarity Pharmaceuticals: SECuRE trial update: First patient treated in the Phase II Cohort ExpansionApril 15, 2025 | finanznachrichten.deClarity Pharmaceuticals Advances SECuRE Trial with Enhanced Prostate Cancer TreatmentApril 14, 2025 | tipranks.comClarity Pharmaceuticals And 2 Other ASX Penny Stocks To WatchApril 14, 2025 | finance.yahoo.comVanguard Group Becomes Substantial Holder in Clarity PharmaceuticalsApril 10, 2025 | tipranks.comWhy is this ASX 200 healthcare share leaping 14% today?March 18, 2025 | msn.comClarity Pharmaceuticals Ltd. (CU6) Gets a Buy from Bell PotterMarch 13, 2025 | markets.businessinsider.comCanaccord Genuity Reaffirms Their Buy Rating on Clarity Pharmaceuticals Ltd. (CU6)March 7, 2025 | markets.businessinsider.comGuess which ASX 200 biotech stock is jumping 7% on big newsMarch 4, 2025 | msn.comClarity Pharmaceuticals Ltd Announces Quotation of New SecuritiesMarch 4, 2025 | tipranks.comClarity Pharmaceuticals Issues New Shares, Strengthening Market PositionMarch 4, 2025 | tipranks.comClarity Pharmaceuticals Secures Copper-64 Supply for Enhanced Cancer DiagnosticsMarch 4, 2025 | tipranks.comWhy is this ASX 200 healthcare share tanking 10% on Tuesday?March 3, 2025 | msn.comClarity Pharmaceuticals Reports Increased Loss but Stronger Asset BaseFebruary 28, 2025 | tipranks.comClarity Pharmaceuticals Reports Key 2025 Interim AchievementsFebruary 28, 2025 | tipranks.comAnother win for Clarity at FDA as imaging agent fast-tracked for complex prostate cancerFebruary 19, 2025 | msn.comClarity Pharmaceuticals Secures FDA Fast Track for Prostate Cancer TreatmentFebruary 18, 2025 | tipranks.comClarity Pharmaceuticals’ 64Cu-SAR-bisPSMA Receives FDA Fast Track DesignationFebruary 17, 2025 | tipranks.com Get Clarity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CU6 and its competitors with MarketBeat's FREE daily newsletter. Email Address CU6 Media Mentions By Week CU6 Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CU6 News Sentiment▼1.570.63▲Average Medical News Sentiment CU6 News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CU6 Articles This Week▼31▲CU6 Articles Average Week Get Clarity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CU6 and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VKTX News Today TGTX News Today ACBFF News Today ACAD News Today PBH News Today KRYS News Today CYTK News Today ADMA News Today ACLX News Today PCVX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CU6) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarity Pharmaceuticals Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Clarity Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access